TY  - JOUR
T1  - NIh reorganization
AU  - Kuehn BM
Y1  - 2012/02/22
N1  - 10.1001/jama.2012.174
JO  - JAMA
SP  - 773
EP  - 773
VL  - 307
IS  - 8
N2  - 
The new center will operate with a budget of $575 million under the leadership of acting director Thomas R. Insel, MD, and acting deputy director Kathy Hudson, PhD, until a permanent director is selected, according to an announcement from NIH. Most of the budget for the new center comes from the closure of the National Center for Research Resources (NCRR) and other programs housed in NIH. Key initiatives of the new center include an effort to identify and fill treatment gaps, Clinical and Translational Science Awards, the Cures Acceleration Network, a Food and Drug Administration–NIH interagency partnership to accelerate the development and evaluation of therapies, and programs to study and develop therapies for rare diseases.

SN  - 0098-7484
M3  - doi: 10.1001/jama.2012.174
UR  - http://dx.doi.org/10.1001/jama.2012.174
ER  -